Table 2.
Comparison of glycaemic parameters, lipid profile and lipid risk factors and other biochemical parameters between control group (participants without diabetes) and diabetes group (patients with diabetes)
| Control Group | Diabetes Group | |
|---|---|---|
| (n = 42) | (n = 42) | |
| Glycemic parameters | ||
| FSG (mg/dL) | 84.95 ± 14.86 | 162.74 ± 75.27*** |
| Insulin (μU/mL) | 3.31 ± 1.27 | 6.76 ± 3.96 ΨΨΨ |
| HOMA-IR | 0.72 ± 0.41 | 3.17 ± 3.04 ΨΨΨ |
| Lipid profile | ||
| TC (mg/dL) | 193.02 ± 38.86 | 175.93 ± 35.45 |
| HDL-C (mg/dL) | 42.88 ± 9.31 | 43.54 ± 9.87 |
| LDL-C (mg/dL) | 131.10 ± 31.53 | 103.60 ± 38.35** |
| TG (mg/dL) | 113.21 ± 84.13 | 144.45 ± 69.27 ΨΨΨ |
| VLDL-C (mg/dL) | 22.64 ± 16.82 | 28.88 ± 13.86 ΨΨΨ |
| Lipid risk factors | ||
| Non HDL-C (mg/dL) | 150.14 ± 38.26 | 132.38 ± 36.23 |
| TG/HDL-C | 2.78 ± 2.11 | 3.78 ± 2.92 Ψ |
| TC/HDL-C | 4.67 ± 1.21 | 4.26 ± 1.33 |
| LDL-C/HDL-C | 3.18 ± 0.95 | 2.52 ± 1.18* |
| AIP | 0.35 ± 0.27 | 0.48 ± 0.27* |
| Inflammatory markers | ||
| hsCRP (mg/L) | 0.72 ± 0.38 | 1.09 ± 1.31Ψ |
| Osteoprotegerin (pg/mL) | 131.20 ± 73.66 | 225.54 ± 128.78 *** |
The values are expressed as Mean ± SD
FSG fasting serum glucose, HOMA-IR homeostatic model assessment of insulin resistance, TC total choleterol, HDL-C high density cholesterol, LDL-C low density cholesterol, TG triglyceride, VLDL-C very low density cholesterol, Non HDL-C non HDL cholesterol, AIP atherogenic index of plasma = log10[TG/HDL-C], hsCRP high-sensitive C-reactive protien
*p < 0.05; **p < 0.01;***p < 0.001 by Student’s unpaired ‘t’ test
Ψp < 0.05; ΨΨΨp < 0.001 by Mann Whitney U test